Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-22-001323

Director sold 4,500 shares at an average $64.71 ($291,177)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
De Backer Marianne Director 2022-01-03 Sale −2,244 $64.25 $144,177 19,256 D: show line 1 in the form
De Backer Marianne Director 2022-01-03 Sale −1,984 $65.01 $128,980 17,272 D: show line 2 in the form
De Backer Marianne Director 2022-01-03 Sale −272 $66.25 $18,020 17,000 D: show line 3 in the form
Open-market sales · 4,500 sh · avg $64.71 · $291,177
Loading xslF345X03/doc4.xml…